Health ❯Healthcare
Patient Care Medical Research Research Clinical Research Public Health Neurology Patient Outcomes Clinical Trials Genetics Medical Technology
The insurer's stock plunges over 6% following a Guardian investigation, as CMS announces expanded audits and leadership struggles continue.